Contact: Andy Hoang
AHoang@salk.edu
619-861-5811
Salk Institute
Caption: A diabetes drug could hold promise for lung cancer patients.
Credit: Courtesy of the Salk Institute for Biological Studies
Usage Restrictions: News media reproduction to illustrate this story permitted with proper attribution as provided above. For one time use only.
Related news release: Diabetes drug could hold promise for lung cancer patients